Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.

Medicine - 1 Oct 2016

Zhuo Xianlu, Song Jue, Liao Jian, Zhou Wei, Ye Huiping, Li Qi, Xiang Zhaolan, Zhang Xueyuan

Abstract excerpt

BACKGROUND: Previous reports showed that CYP2E1 RsaI/PstI polymorphism may be a risk factor for cancers. Published meta-analyses in 2010 and 2011, respectively, on the relationship of CYP2E1 RsaI/PstI polymorphisms with the susceptibility to head and neck carcinoma (HNC) have generated inconsistent results. Thus, this study aimed to conduct an updated meta-analysis involving published studies up to Nov 2015 to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Cytochrome P-450 CYP2E1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Head and Neck Neoplasms

Share to Polymorphism, Genetic

Share to Squamous Cell Carcinoma of Head and Neck

Source

Open in PubMed Open full text

Identifiers

PMID: 27787372
DOI: 10.1097/MD.0000000000005156
PMCID: PMC5089101

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.PMID 27787372Read ↗

Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer.Semantic proximity Read ↗

CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.Semantic proximity Read ↗

CYP2E1 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis.Semantic proximity Read ↗

CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.Semantic proximity Read ↗

The polymorphism of CYP2E1 Rsa I/Pst I gene and susceptibility to respiratory system cancer: a systematic review and meta-analysis of 34 studies.Semantic proximity Read ↗

Updated meta-analysis of the association between CYP2E1 RsaI/PstI polymorphisms and lung cancer risk in Chinese population.Semantic proximity Read ↗

CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls.Semantic proximity Read ↗

CYP2E1 RsaI/PstI polymorphism and liver cancer risk among east Asians: a HuGE review and meta-analysis.Semantic proximity Read ↗

CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians.Semantic proximity Read ↗

CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.